<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Proc Natl Acad Sci U S A</journal-id>
<journal-id journal-id-type="iso-abbrev">Proc. Natl. Acad. Sci. U.S.A</journal-id>
<journal-id journal-id-type="hwp">pnas</journal-id>
<journal-id journal-id-type="pmc">pnas</journal-id>
<journal-id journal-id-type="publisher-id">PNAS</journal-id>
<journal-title-group>
<journal-title>Proceedings of the National Academy of Sciences of the United States of America</journal-title>
</journal-title-group>
<issn pub-type="ppub">0027-8424</issn>
<issn pub-type="epub">1091-6490</issn>
<publisher>
<publisher-name>National Academy of Sciences</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">29386386</article-id>
<article-id pub-id-type="pmc">5816211</article-id>
<article-id pub-id-type="publisher-id">201721290</article-id>
<article-id pub-id-type="doi">10.1073/pnas.1721290115</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Biological Sciences</subject>
<subj-group>
<subject>Genetics</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>De novo mutation in <italic>RING1</italic> with epigenetic effects on neurodevelopment</article-title>
<alt-title alt-title-type="short"><italic>RING1</italic> in neurodevelopment</alt-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Pierce</surname>
<given-names>Sarah B.</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>a</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Stewart</surname>
<given-names>Mikaela D.</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>b</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Gulsuner</surname>
<given-names>Suleyman</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>a</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Walsh</surname>
<given-names>Tom</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>a</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Dhall</surname>
<given-names>Abhinav</given-names>
</name>
<xref ref-type="aff" rid="aff3">
<sup>c</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>McClellan</surname>
<given-names>Jon M.</given-names>
</name>
<xref ref-type="aff" rid="aff4">
<sup>d</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<contrib-id authenticated="false" contrib-id-type="orcid">http://orcid.org/0000-0002-3476-969X</contrib-id>
<name>
<surname>Klevit</surname>
<given-names>Rachel E.</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>b</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>King</surname>
<given-names>Mary-Claire</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>a</sup>
</xref>
<xref ref-type="aff" rid="aff5">
<sup>e</sup>
</xref>
<xref ref-type="corresp" rid="cor1">
<sup>1</sup>
</xref>
</contrib>
<aff id="aff1"><sup>a</sup>Department of Medicine, <institution>University of Washington</institution>, Seattle, <addr-line>WA</addr-line> 98195;</aff>
<aff id="aff2"><sup>b</sup>Department of Biochemistry, <institution>University of Washington</institution>, Seattle, <addr-line>WA</addr-line> 98195;</aff>
<aff id="aff3"><sup>c</sup>Department of Chemistry, <institution>University of Washington</institution>, Seattle, <addr-line>WA</addr-line> 98195;</aff>
<aff id="aff4"><sup>d</sup>Department of Psychiatry, <institution>University of Washington</institution>, Seattle, <addr-line>WA</addr-line> 98195;</aff>
<aff id="aff5"><sup>e</sup>Department of Genome Sciences, <institution>University of Washington</institution>, Seattle, <addr-line>WA</addr-line> 98195</aff>
</contrib-group>
<author-notes>
<corresp id="cor1"><sup>1</sup>To whom correspondence should be addressed. Email: <email>mcking@uw.edu</email>.</corresp>
<fn fn-type="edited-by">
<p>Contributed by Mary-Claire King, January 6, 2018 (sent for review December 7, 2017; reviewed by H. Robert Horvitz and Matthew State)</p>
</fn>
<fn fn-type="con">
<p>Author contributions: S.B.P., M.D.S., S.G., T.W., J.M.M., R.E.K., and M.-C.K. designed research; S.B.P., M.D.S., S.G., T.W., A.D., J.M.M., R.E.K., and M.-C.K. performed research; A.D. contributed new reagents/analytic tools; S.B.P., M.D.S., S.G., T.W., A.D., J.M.M., R.E.K., and M.-C.K. analyzed data; and S.B.P., M.D.S., J.M.M., R.E.K., and M.-C.K. wrote the paper.</p>
</fn>
<fn fn-type="con">
<p>Reviewers: H.R.H., Massachusetts Institute of Technology; and M.S., University of California, San Francisco.</p>
</fn>
<fn fn-type="COI-statement">
<p>The authors declare no conflict of interest.</p>
</fn>
</author-notes>
<pub-date pub-type="ppub">
<day>13</day>
<month>2</month>
<year>2018</year>
</pub-date>
<pub-date pub-type="epub">
<day>31</day>
<month>1</month>
<year>2018</year>
</pub-date>
<volume>115</volume>
<issue>7</issue>
<fpage>1558</fpage>
<lpage>1563</lpage>
<permissions>
<copyright-year>2018</copyright-year>
<license>
<ali:license_ref specific-use="vor" xmlns:ali="http://www.niso.org/schemas/ali/1.0/"></ali:license_ref>
<license-p>Published under the <ext-link ext-link-type="uri" xlink:href="http://www.pnas.org/site/aboutpnas/licenses.xhtml">PNAS license</ext-link>.</license-p>
</license>
</permissions>
<self-uri xlink:href="pnas.201721290.pdf" xlink:title="pdf"></self-uri>
<abstract abstract-type="executive-summary">
<title>Significance</title>
<p>As part of the polycomb repressive complex 1, RING1 contributes to epigenetic regulation of gene expression during development. We identified a de novo mutation in <italic>RING1</italic> in a patient with neurological, skeletal, and immunological abnormalities. The mutation disrupts the ability of RING1 to ubiquitylate histone H2A in nucleosomes, without disrupting its ability to catalyze ubiquitin chain formation. The comparable mutation in <italic>Caenorhabditis elegans</italic> causes defects in neuronal development that are as severe as defects caused by a complete loss of gene function. These results identify <italic>RING1</italic> as critical to neurodevelopment via its involvement in chromatin modification and epigenetic transcriptional regulation.</p>
</abstract>
<abstract>
<p>RING1 is an E3-ubiquitin ligase that is involved in epigenetic control of transcription during development. It is a component of the polycomb repressive complex 1, and its role in that complex is to ubiquitylate histone H2A. In a 13-year-old girl with syndromic neurodevelopmental disabilities, we identified a de novo mutation, RING1 p.R95Q, which alters a conserved arginine residue in the catalytic RING domain. In vitro assays demonstrated that the mutant RING1 retains capacity to catalyze ubiquitin chain formation, but is defective in its ability to ubiquitylate histone H2A in nucleosomes. Consistent with this in vitro effect, cells of the patient showed decreased monoubiquitylation of histone H2A. We modeled the mutant RING1 in <italic>Caenorhabditis elegans</italic> by editing the comparable amino acid change into <italic>spat-3</italic>, the suggested <italic>RING1</italic> ortholog. Animals with either the missense mutation or complete knockout of <italic>spat-3</italic> were defective in monoubiquitylation of histone H2A and had defects in neuronal migration and axon guidance. Relevant to our patient, animals heterozygous for either the missense or knockout allele also showed neuronal defects. Our results support three conclusions: mutation of <italic>RING1</italic> is the likely cause of a human neurodevelopmental syndrome, mutation of <italic>RING1</italic> can disrupt histone H2A ubiquitylation without disrupting RING1 catalytic activity, and the comparable mutation in <italic>C. elegans spat-3</italic> both recapitulates the effects on histone H2A ubiquitylation and leads to neurodevelopmental abnormalities. This role for <italic>RING1</italic> adds to our understanding of the importance of aberrant epigenetic effects as causes of human neurodevelopmental disorders.</p>
</abstract>
<kwd-group>
<kwd>RING1</kwd>
<kwd>histone H2A</kwd>
<kwd>psychosis</kwd>
<kwd>ubiquitin</kwd>
<kwd>CRISPR/Cas9</kwd>
</kwd-group>
<funding-group>
<award-group id="gs1">
<funding-source id="sp1">HHS | National Institutes of Health (NIH)<named-content content-type="funder-id">100000002</named-content></funding-source>
<award-id rid="sp1">R01MH083989</award-id>
</award-group>
<award-group id="gs2">
<funding-source id="sp2">HHS | National Institutes of Health (NIH)<named-content content-type="funder-id">100000002</named-content></funding-source>
<award-id rid="sp2">R01GM088055</award-id>
</award-group>
<award-group id="gs3">
<funding-source id="sp3">HHS | National Institutes of Health (NIH)<named-content content-type="funder-id">100000002</named-content></funding-source>
<award-id rid="sp3">T32CA080416</award-id>
</award-group>
</funding-group>
<counts>
<page-count count="6"></page-count>
</counts>
</article-meta>
</front>
</article>
</pmc-articleset>